Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1942 3
1952 1
1953 1
1958 1
1959 1
1960 1
1961 1
1963 1
1988 1
1989 3
1990 3
1991 2
1992 3
1993 5
1994 4
1995 7
1996 7
1997 1
1998 8
1999 10
2000 10
2001 6
2002 8
2003 9
2004 9
2005 8
2006 10
2007 9
2008 10
2009 8
2010 9
2011 4
2012 11
2013 19
2014 25
2015 27
2016 27
2017 18
2018 14
2019 14
2020 15
2021 15
2022 10
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

319 results
Results by year
Filters applied: . Clear all
Page 1
Reply.
Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, Williams J, Livingston SE. Simonetti J, et al. Among authors: negus s. Hepatology. 2016 Aug;64(2):690-1. doi: 10.1002/hep.28501. Epub 2016 Apr 5. Hepatology. 2016. PMID: 26890566 No abstract available.
Confronting the opioid crisis with basic research in neuropharmacology.
Baumann MH, Pasternak GW, Negus SS. Baumann MH, et al. Among authors: negus ss. Neuropharmacology. 2020 Apr;166:107972. doi: 10.1016/j.neuropharm.2020.107972. Epub 2020 Jan 17. Neuropharmacology. 2020. PMID: 31958407 Free PMC article. No abstract available.
Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.
Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. Jaster AM, et al. Among authors: negus ss. Psychopharmacology (Berl). 2022 Jun;239(6):1665-1677. doi: 10.1007/s00213-022-06092-x. Epub 2022 Mar 2. Psychopharmacology (Berl). 2022. PMID: 35233648
Medications Development for Treatment of Opioid Use Disorder.
Townsend EA, Negus SS, Banks ML. Townsend EA, et al. Among authors: negus ss. Cold Spring Harb Perspect Med. 2021 Jan 4;11(1):a039263. doi: 10.1101/cshperspect.a039263. Cold Spring Harb Perspect Med. 2021. PMID: 31932466 Free PMC article. Review.
Medications development for opioid abuse.
Negus SS, Banks ML. Negus SS, et al. Cold Spring Harb Perspect Med. 2013 Jan 1;3(1):a012104. doi: 10.1101/cshperspect.a012104. Cold Spring Harb Perspect Med. 2013. PMID: 23125072 Free PMC article. Review.
Abuse Potential of Biased Mu Opioid Receptor Agonists.
Negus SS, Freeman KB. Negus SS, et al. Trends Pharmacol Sci. 2018 Nov;39(11):916-919. doi: 10.1016/j.tips.2018.08.007. Trends Pharmacol Sci. 2018. PMID: 30343727 Free PMC article. Review.
Factors mediating pain-related risk for opioid use disorder.
Nazarian A, Negus SS, Martin TJ. Nazarian A, et al. Among authors: negus ss. Neuropharmacology. 2021 Mar 15;186:108476. doi: 10.1016/j.neuropharm.2021.108476. Epub 2021 Jan 30. Neuropharmacology. 2021. PMID: 33524407 Free PMC article. Review.
319 results